Report for: Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era

Title	Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era
Published in	PLOS ONE, March 2012
DOI	10.1371/journal.pone.0033684
Pubmed ID	22479427
Authors	Christine Carico, Miriam Nuño, Debraj Mukherjee, Adam Elramsisy, Jocelynn Dantis, Jethro Hu, Jeremy Rudnick, John S. Yu, Keith L. Black, Serguei I. Bannykh, Chirag G. Patil
Abstract	Pre-temozolomide studies demonstrated that loss of the tumor suppressor gene PTEN held independent prognostic significance in GBM patients. We investigated whether loss of PTEN predicted shorter survival in the temozolomide era. The role of PTEN in the PI3K/Akt pathway is also reviewed.

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	1	100%

Type	Count	As %
Scientists	1	100%

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Student > Ph. D. Student	17	19%
Student > Master	13	15%
Student > Bachelor	9	10%
Researcher	9	10%
Student > Postgraduate	8	9%
Other	17	19%
Unknown	15	17%

Readers by discipline	Count	As %
Medicine and Dentistry	31	35%
Biochemistry, Genetics and Molecular Biology	20	23%
Agricultural and Biological Sciences	9	10%
Neuroscience	8	9%
Pharmacology, Toxicology and Pharmaceutical Science	1	1%
Other	4	5%
Unknown	15	17%

PLOS